Changes in Condom Use During the First Year of HIV Treatment in Uganda and the Relationship to Depression

Published in: Annals of Behavioral Medicine, v. 48, no. 2, Oct. 2014, p. 175-183

Posted on RAND.org on January 01, 2014

by Glenn Wagner, Bonnie Ghosh-Dastidar, Mary Ellen Slaughter, Dickens Akena, Noeline Nakasujja, Seggane Musisi

Read More

Access further information on this document at rd.springer.com

This article was published outside of RAND. The full text of the article can be found at the link above.

PURPOSE: We examined the effect of antiretroviral therapy (ART), and the predictive role of depression, on condom use with primary partners. METHODS: Data from three studies in Uganda were combined into a sample of 750 patients with a primary sex partner, with 502 starting ART and 248 entering HIV care, and followed for 12 months. Random-effects logistic regression models were used to examine the impact of ART, and the influence of baseline level and change in depression, on condom use with primary partners. RESULTS: At month 12, 61% ART and 67% non-ART patients were consistent condom users, compared to 44 and 41% at baseline, respectively. Multivariate analysis revealed that consistent condom use increased similarly for ART and non-ART patients, and that minor depression at baseline and increased depression over time predicted inconsistent condom use. CONCLUSIONS: Improved depression diagnosis and treatment could benefit HIV prevention.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.